Monopar Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
20 Jun 24 | Buy€23,866 | Andrew Cittadine | Individual | 6,501.6 | €4.01 | |
17 Jun 24 | Buy€30,677 | Andrew Cittadine | Individual | 7,200 | €4.34 | |
04 Jun 24 | Buy€16,983 | Andrew Cittadine | Individual | 4,800 | €3.58 | |
31 May 24 | Buy€21,255 | Andrew Cittadine | Individual | 7,200 | €2.97 |
Insider Trading Volume
Insider Buying: 1IY0 insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 83,630 | 2.38% |
Individual Insiders | 409,366 | 11.6% |
Private Companies | 1,466,666 | 41.7% |
General Public | 1,560,703 | 44.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,466,666 | €3.4m | 0% | no data | |||
138,560 | €320.5k | 0% | no data | |||
93,750 | €216.9k | 0% | no data | |||
53,185 | €123.0k | 60.1% | no data | |||
47,173 | €109.1k | 0% | no data | |||
38,859 | €89.9k | 1% | no data | |||
38,613 | €89.3k | 235% | no data | |||
15,053 | €34.8k | 0% | no data | |||
12,007 | €27.8k | 45.7% | no data | |||
11,486 | €26.6k | 13.8% | no data | |||
9,411 | €21.8k | 0% | no data | |||
9,033 | €20.9k | 0% | no data | |||
6,173 | €14.3k | 0% | no data | |||
5,601 | €13.0k | 0% | 0.01% | |||
5,373 | €12.4k | 0% | no data | |||
3,768 | €8.7k | -20.9% | no data | |||
2,139 | €4.9k | 0% | no data | |||
1,584 | €3.7k | 0.83% | no data | |||
600 | €1.4k | 0% | no data | |||
500 | €1.2k | 66.7% | no data | |||
112 | €259.0 | 12% | no data | |||
16 | €36.6 | 0% | no data |